UBS analyst Brian Meredith raised the firm’s price target on Axis Capital (AXS) to $129 from $126 and keeps a Buy rating on the shares. Insurance brokers are well positioned for 2026, with organic revenue growth averaging 4.4% and EBITDA margins improving year over year despite property rate pressures, the analyst tells investors in a research note. With growth expectations reset and valuations reflecting a softer market, there is upside to consensus EPS and potential for multiple expansion, the firm says.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
- Axis Capital Delivers Record Results, Stays Disciplined
- Axis Capital Grants Special Equity Award to CEO
- Axis Capital price target raised to $130 from $125 at RBC Capital
- Axis Capital price target raised to $122 from $121 at Jefferies
- Axis Capital price target raised to $120 from $110 at Roth Capital